Lucie Obéric

Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial

Michael Wang, Simon Rule, Pier Luigi Zinzani et al. · The Lancet · 2017 · 448 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma

Steven Le Gouill, Catherine Thiéblemont, Lucie Obéric et al. · New England Journal of Medicine · 2017 · 412 citations · Full text

Life Sciences, Immunology, Oncology +16

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Laëtitia Vercellino, Roberta Di Blasi, Salim Kanoun et al. · Blood Advances · 2020 · 404 citations · Full text

Medicine, Oncology, Cell Therapy +16

Management and outcome of primary CNS lymphoma in the modern era

Caroline Houillier, Carole Soussain, Hervé Ghesquières et al. · Neurology · 2020 · 245 citations · Full text

Medicine, Oncology, Chemotherapy +12

Lenalidomide Maintenance Compared With Placebo in Responding Elderly Patients With Diffuse Large B-Cell Lymphoma Treated With First-Line Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Catherine Thiéblemont, Hervé Tilly, María Gomes da Silva et al. · Journal of Clinical Oncology · 2017 · 195 citations

Medicine, Oncology, Pharmacotherapy +14